Statement of the Board of Directors of Evox Rifa Group Oyj concerning the tender offer of KEMET Electronics Corporation

Evox Rifa Group Oyj (“Evox”) and KEMET Corporation have on 19 February
2007 entered into a Combination Agreement, pursuant to which KEMET
Corporation's wholly owned subsidiary KEMET Electronics Corporation
(“KEMET”) makes an offer for all shares and convertible loan notes of
Evox. The Board of Directors of Evox gives this statement pursuant to
Chapter 6 Section 6 of the Securities Markets Act having received from
KEMET its Tender Offer Document on 9 March 2007.
KEMET offers to the Evox shareholders an offer consideration of EUR
0.12 per share in cash and, to the holders of each convertible loan
note, the aggregate of the nominal amount of EUR 100 plus accrued
interest up to and including the closing date of the tender offer
payable in cash. The per share offer consideration is approximately 38
per cent higher than the one month volume-weighted average trading
price, approximately 44 per cent higher than the three months' volume-
weighted average trading price and approximately 46 per cent higher
than the twelve months' volume-weighted average trading price for the
time period prior to the announcement of the tender offer (calculated
based upon the daily trading information of the Helsinki Stock
Exchange). The per share offer consideration of EUR 0.12 is lower than
the EUR 0.1333 conversion rate of the convertible capital loan notes.
Evox has a strong market position in selected target markets, a high
level of engineering capability and long-standing customer
relationships. Evox operates in a global and highly competitive market
in which demand and production has, in recent years, transferred to
Asia, especially China. Evox is significantly smaller than its global
competitors, and while the demand for its products is growing, the
electronics business is cyclical in nature. Maintaining
competitiveness demands continued investment in production process
improvement and the development of new products and technologies. In
the opinion of the Board of Directors of Evox, the market position of
the company can be further strengthened and the aforementioned changes
in the business environment better managed together with a business
partner, and a combination with KEMET is a better solution for the
shareholders than to continue as an independent company.

The Board of Directors considers KEMET to be a strategic buyer
interested in entering into new market segments and customer
applications. The products, manufacturing structure and customers of
Evox are not significantly overlapping those of KEMET. By utilizing
its strong financial position, KEMET has the opportunity to further
develop Evox's business and accelerate its growth through capital
investments and research and development.

KEMET plans to integrate Evox's business into KEMET's global
organization based upon an integration plan still to be developed. As
far as the Board of Directors is aware, KEMET intends to continue the
business of Evox without significant changes for the time being. The
Board of Directors of Evox is not aware of KEMET having planned major
changes to manufacturing sites of Evox, although KEMET will continue
to require that each manufacturing site will have to generate positive
cash flow and be competitive in the marketplace.
The Board of Directors is not aware of any changes in terms of
employment or number of jobs in Evox as a result of the Tender Offer.

The Board of Directors have investigated the possibilities of
strengthening Evox's business prospects through mergers or
partnerships. These investigations have not lead to serious offers or
proposals to buy Evox's shares.

Evox has granted KEMET sixty (60) days of exclusivity to negotiate the
Combination Agreement and conduct a due diligence review. The
exclusivity period started on 15 January 2007 and since that date
Evox's Board of Directors has not been in contact with other potential
buyers. The Board of Directors is not aware of any party contemplating
a comparable offer.

In order to evaluate the offer made by KEMET, the Board has requested
Advium Corporate Finance, eQ Pankki Oy (“Advium”) to provide a
fairness opinion. According to the opinion given by Advium, on 18
February 2007 and based on assumptions given in the opinion, the
consideration offered by KEMET to the shareholders and to the holders
of convertible capital loan notes is fair.

Considering the aforementioned information, the Board is of the
opinion that the offer consideration offered in KEMET's tender offer
is fair from the perspective of the shareholders and holders of
convertible capital loan notes, as a result of which the Board
recommends the shareholders and holders of convertible capital loan
notes to accept the tender offer.

Evox shareholders Fennogens Investments S.A., Veikko Laine Oy, Mr. Wee
Cheng Hoon, Mr. Henrik Ehrnrooth and Mr. Pertti Laine representing
approximately 51.7 per cent of the share capital of Evox, have
undertaken irrevocably and unconditionally to accept the tender offer.
Two members of the Evox Board, Mr. Henrik Ehrnrooth and Mr. Pertti
Laine, have not participated in and will not participate in the Board
of Directors' decisions on this transaction due to the potential
conflict of interest relating to the said commitments towards KEMET.

KEMET'S tender offer is subject to the valid tender of shares and
convertible capital loan notes representing more than two thirds (2/3)
of all shares and votes of Evox. Should KEMET obtain more than nine
tenths (9/10) of the shares and votes of Evox, KEMET intends to
initiate compulsory acquisition proceedings under the Finnish
Companies Act. Furthermore, if KEMET obtains less than nine tenths
(9/10) but more than two thirds (2/3) of the shares and votes of Evox,
KEMET may consider combining the operations of Evox through a merger
under Chapter 16 of the Companies Act and for this purpose KEMET
reserves the right to transfer the offer to a wholly owned Finnish
subsidiary of KEMET Corporation (the parent company of KEMET).
If KEMET receives more than nine tenths (9/10) of the shares and votes
of Evox, the holders of convertible capital loan notes shall be
offered an opportunity to convert their loan notes to shares in Evox
during a specific time period decided by the Board of Directors, after
which the right to convert the convertible capital loan notes to Evox
shares will cease.
Despite the positive recommendation of the Board of Directors each
shareholder and holder of convertible capital loan notes must
independently decide whether to accept the offer of KEMET taking into
consideration all information presented in KEMET's Tender Offer
Document and other possible matters affecting the tender offer.

Espoo, 9 March 2007

The Board of Directors of Evox Rifa Group Oyj

Further information from:  Vice Chairman Jerker Molander, tel: +358
50 380 3845

Distribution: Helsinki Stock Exchange, principal media